SELECTA BIOSCIENCES INC·4

Sep 22, 5:30 PM ET

Siewers David 4

4 · SELECTA BIOSCIENCES INC · Filed Sep 22, 2017

Insider Transaction Report

Form 4
Period: 2017-09-20
Siewers David
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-09-20$0.63/sh+2,194$1,3822,194 total
  • Sale

    Common Stock

    2017-09-20$20.00/sh2,194$43,8800 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2017-09-2014,2305,000 total
    Exercise: $0.63Exp: 2021-02-16Common Stock (14,230 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2017-09-202,1940 total
    Exercise: $0.63Exp: 2020-09-06Common Stock (2,194 underlying)
  • Exercise/Conversion

    Common Stock

    2017-09-20$0.63/sh+14,230$8,96514,230 total
  • Sale

    Common Stock

    2017-09-20$20.00/sh14,230$284,6000 total
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
  • [F2]All shares underlying this option are fully vested.

Documents

1 file
  • 4
    doc4_4980.xmlPrimary

    PRIMARY DOCUMENT